Farmacia Hospitalaria y Farmacogenómica

Duran, PA; Jimenez, RMR; Compes, CC; Alvarez, MC; Lesmes, IB; Pinto, AD; Bravo, SB; Soriano, LF; Peris, PG; Saez, MS.

HOME PARENTERALNUTRITION; SATISFACTION OF PATIENTS AND THEIR CAREGIVERS WITH NUTRITION UNIT AND PHARMACY SERVICE

NUTRICION HOSPITALARIA. 2014; 29(5): 1123-1131 Nº de citas: 2 [doi:10.3305/nh.2014.29.5.7371]

Manrique-Rodriguez, S; Sanchez-Galindo, AC; Lopez-Herce, J; Calleja-Hernandez, MA; Iglesias-Peinado, I; Carrillo-Alvarez, A; Saez, MS; Fernandez-Llamazares, CM.

RISKS IN THE IMPLEMENTATION AND USE OF SMART PUMPS IN A PEDIATRIC INTENSIVE CARE UNIT: APPLICATION OF THE FAILURE MODE AND EFFECTS ANALYSIS

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2014; 30(2): 210-217 Nº de citas: 17 [doi:10.1017/S0266462314000051]

Perez-Granda, MJ; Barrio, JM; Munoz, P; Hortal, J; Rincon, C; Rabadan, PM; Pernia, MS; Bouza, E.

Ethanol Lock Therapy (E-Lock) in the Prevention of Catheter-Related Bloodstream Infections (CR-BSI) after Major Heart Surgery (MHS): A Randomized Clinical Trial

PLoS One. 2014; 9(3): Nº de citas: 25 [doi:10.1371/journal.pone.0091838]

Manrique-Rodriguez, S; Sanchez-Galindo, AC; Lopez-Herce, J; Calleja-Hernandez, MA; Martinez-Martinez, F; Iglesias-Peinado, I; Carrillo-Alvarez, A; Sanjurjo-Saez, M; Fernandez-Llamazares, CM.

Implementing smart pump technology in a pediatric intensive care unit: A cost-effective approach

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2014; 83(2): 99-105 Nº de citas: 17 [doi:10.1016/j.ijmedinf.2013.10.011]

Manrique-Rodríguez S; Sánchez-Galindo A; Fernández-Llamazares CM; López-Herce J; Rodríguez-Gómez M; Echarri-Martínez L; Carrillo-Álvarez A; Sanjurjo-Sáez M.

Preparation of intravenous drug administration guidelines for a pediatric intensive care unit.

Journal Of Infusion Nursing : The Official Publication Of The Infusion Nurses Society. 2014; 37(1): 35-43 Nº de citas: 2 [doi:10.1097/NAN.0000000000000019]

Arrabal-Duran, P; Duran-Garcia, ME; Ribed-Sanchez, A; Hidalgo-Collazos, P; Sanjurjo-Saez, M.

Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure

NEFROLOGIA. 2014; 34(6): 710-715 Nº de citas: 8 [doi:10.3265/Nefrologia.pre2014.Jul.12541]

de Lorenzo-Pinto, A; Sanchez-Galindo, AC; Manrique-Rodriguez, S; Fernandez-Llamazares, CM; Fernandez-Lafever, SN; San-Prudencio, MG; Cortejoso, L; Sanjurjo-Saez, M.

Prevention and treatment of intraluminal catheter thrombosis in children hospitalised in a paediatric intensive care unit

JOURNAL OF PAEDIATRICS AND CHILD HEALTH. 2014; 50(1): 40-46 Nº de citas: 6 [doi:10.1111/jpc.12404]

Vega, A; Abad, S; Verdalles, U; Aragoncillo, I; Velazquez, K; Quiroga, B; Escudero, V; Lopez-Gomez, JM.

Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease

Hippokratia. 2014; 18(4): 315-318 Nº de citas: 14

Sanchez, AR; Jimenez, RMR; de Orgaz, MCSG; Luna, MS; Saez, MS.

Aggressive parenteral nutrition and growth velocity in preterm infants

NUTRICION HOSPITALARIA. 2013; 28(6): 2128-2134 Nº de citas: 5 [doi:10.3305/nh.2013.28.6.6961]

Manrique-Rodriguez, S; Sanchez-Galindo, AC; Lopez-Herce, J; Calleja-Hernandez, MA; Martinez-Martinez, F; Iglesias-Peinado, I; Carrillo-Alvarez, A; Saez, MS; Fernandez-Llamazares, CM.

Impact of implementing smart infusion pumps in a pediatric intensive care unit

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. 2013; 70(21): 1897-1906 Nº de citas: 45 [doi:10.2146/ajhp120767]

Lasarte, S; Elsner, D; Sanchez-Elsner, T; Fernandez-Pineda, A; Lopez-Fernandez, LA; Corbi, AL; Munoz-Fernandez, MA; Relloso, M.

Estradiol downregulates NF-kappa b translocation by Ikbkg transcriptional repression in dendritic cells

GENES IMMUN. 2013; 14(7): 462-469 Nº de citas: 15 [doi:10.1038/gene.2013.35]

Moral, L; Torres-Borrego, J; Murua, JK; Valverde-Molina, J; Belinchon, JP; Praena-Crespo, M; Casanueva, CO; Callen-Blecua, MT; Fernandez-Llamazares, CM; Rey, CC.

Association between paracetamol exposure and asthma: update and practice guidelines

ANALES DE PEDIATRIA. 2013; 79(3): 188-188 Nº de citas: 2 [doi:10.1016/j.anpedi.2012.12.006]

Lopez, MCM; Romero, AJA; Lopez, ABM; Fernandez-Llamazares, CM; Navarro, CR.

Risk assessment of thrombotic events after the use of activated factor VII

ANALES DE PEDIATRIA. 2013; 79(3): 177-181 [doi:10.1016/j.anpedi.2012.11.006]

Jimenez, RMR; Lopez, MSP; Fresneda, MNS; Saez, MS.

VALIDATION OF ASEPTIC TECHNIQUE OF PARENTERAL NUTRITION COMPOUNDING IN A PHARMACY SERVICE ACCORDING TO USP CHAPTER 797

NUTRICION HOSPITALARIA. 2013; 28(5): 1494-1497

Fernandez-Llamazares, CM; Pozas, M; Feal, B; Cabanas, MJ; Villaronga, M; Hernandez-Gago, Y; de Villegas, MR; Alvarez-del-Vayo, C.

Profile of prescribing errors detected by clinical pharmacists in paediatric hospitals in Spain

International Journal of Clinical Pharmacy. 2013; 35(4): 638-646 Nº de citas: 23 [doi:10.1007/s11096-013-9785-9]

Ramirez-Herraiz, E; Escudero-Vilaplana, V; Alanon-Plaza, E; Trovato-Lopez, N; Herranz-Alonso, A; Morell-Baladron, A; Sanjurjo-Saez, M.

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013; 31(4): 559-565 Nº de citas: 28

Fernandez-Rozadilla, C; Cazier, JB; Moreno, V; Crous-Bou, M; Guino, E; Duran, G; Lamas, MJ; Lopez, R; Candamio, S; Gallardo, E; Pare, L; Baiget, M; Paez, D; Lopez-Fernandez, LA; Cortejoso, L; Garcia, MI; Bujanda, L; Gonzalez, D; Gonzalo, V; Rodrigo, L; Rene, JM; Jover, R; Brea-Fernandez, A; Andreu, M; Bessa, X; Llor, X; Xicola, R; Palles, C; Tomlinson, I; Castellvi-Bel, S; Castells, A; Ruiz-Ponte, C; Carracedo, A.

Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration

PHARMACOGENOMICS JOURNAL. 2013; 13(3): 209-217 Nº de citas: 46 [doi:10.1038/tpj.2012.2]

Cortejoso, L; Garcia, MI; Garcia-Alfonso, P; Gonzalez-Haba, E; Escolar, F; Sanjurjo, M; Lopez-Fernandez, LA.

Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2013; 71(6): 1463-1472 Nº de citas: 45 [doi:10.1007/s00280-013-2145-6]